Eliquis (apixaban)

pCPA File Number: 20849

Negotiation Status:

Concluded with an LOI

Indication(s):

Thromboembolic events (venous), treatment and prevention of recurrence

Sponsor/Manufacturer:

Bristol Myers Squibb Canada Inc.

CDA-AMC Project Number:

SR0397-000

pCPA Engagement Letter Issued:

2015-06-11

Negotiation Process Concluded:

2015-07-09